Currently out of the existing stock ratings of Charles Rhyee, 183 are a BUY (80.97%), 41 are a HOLD (18.14%), 2 are a SELL (0.88%).

Charles Rhyee

Work Performance Price Targets & Ratings Chart

Analyst Charles Rhyee, currently employed at TD COWEN, carries an average stock price target met ratio of 67.18% that have a potential upside of 25.17% achieved within 288 days. Previously, Charles Rhyee worked at COWEN.

Charles Rhyee’s has documented 455 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CRL, Charles River Laboratories at 11-Nov-2024.

Wall Street Analyst Charles Rhyee

Analyst best performing recommendations are on CSLT (CASTLIGHT HEALTH).
The best stock recommendation documented was for CSLT (CASTLIGHT HEALTH) at 8/4/2021. The price target of $1.9 was fulfilled within 1 day with a profit of $0.16 (7.77%) receiving and performance score of 77.67.

Average potential price target upside

of $68.37 (38.33%) on CI (CIGNA CORP).
of $63.44 (17.24%) on HUM (HUMANA).
of $54.53 (22.68%) on MCK (MCKESSON).

ABC AmerisourceBergen CERN Cerner Corp CHNG Change Healthcare CI Cigna Corp CSLT Castlight Health CVS CVS Health Corp DRIO DarioHealth Corp EVH Evolent Health GDRX Goodrx Holdings HUM Humana MCK McKesson MDRX Allscripts Healthcare Solutions OTRK Ontrak OWLT Owlet RAD Rite Aid SNCE Science 37 Holdings TDOC Teladoc WBA Walgreens Boots Alliance AMWL American Well Corp RCM R1 RCM CAH Cardinal Health PEAR Pear Therapeutics HLTH Cue Health CNC Centene Corp UNH UnitedHealth Group orporated ATHN athenahealth BTTX Better Therapeutics MOH Molina Healthcare VEEV Veeva Systems WBMD WebMD Health Corp IQV IQVIA Holdings TALK Talkspace CRL Charles River Laboratories

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Charles Rhyee (TD COWEN)